Target intelligence / Profile preview

Wnt-3a protein (Wnt3A)

Target
Wnt3A
Molecular classification
Secreted glycoprotein, Ligand, Proto-oncogene product, Wnt protein family
01

Overview

Wnt-3a protein (Wnt3A) is a secreted glycoprotein belonging to the Wnt family that acts as a critical ligand in the canonical Wnt/β-catenin signaling pathway[1][4]. Upon secretion, Wnt-3a binds to cell-surface Frizzled (FZD) receptors and LRP5/6 co-receptors, leading to the inhibition of β-catenin destruction. This allows β-catenin to accumulate in the cytoplasm and translocate to the nucleus, where it activates transcription of genes regulating cell proliferation, cell fate, and differentiation[1][5][7]. Wnt-3a is essential for embryonic development, stem cell maintenance, neural and skeletal patterning, intestinal stem cell proliferation, and hematopoiesis[4][7][9]. Aberrant Wnt3A signaling promotes oncogenesis and can drive the growth of certain cancers by continuously activating Wnt target genes[1][4][7]. Wnt3A requires lipid modification by Porcupine (PORCN) and interaction with the transporter protein Wntless (WLS) for secretion; these processes are current drug targets in Wnt-driven diseases[2][8]. If instead you are referring to the broader "Wnt signaling pathway" as the target, substitute the canonical_name with "Wnt signaling pathway," set canonical_abbreviation to null, and molecular_classifications to "Signaling pathway." However, for drug targeting and biomarker use, the Wnt-3a protein is the actionable molecular target.

Other names
WNT3AProtein Wnt-3a
02

Mechanism of action

Inhibition of Wnt ligand secretion (via PORCN inhibition) Antagonism of Wnt binding to Frizzled/LRP5/6 receptors

03

Biological functions

Signal transductionCell proliferationCell differentiationEmbryonic developmentStem cell regulationTissue homeostasisCell fate determination
04

Disease associations

CancerDevelopmental disordersNeurogenesis disordersHematopoietic diseasesGastrointestinal diseases
05

Safety considerations

Toxicity in tissues dependent on Wnt signaling (intestine, bone, hematopoiesis)Impairment of stem/progenitor cell function
06

Interacting drugs

PORCN inhibitors (e.g., LGK974, ETC-159)

1 more in the full profile.

07

Biomarkers

Nuclear and cytoplasmic β-catenin (as a readout of canonical Wnt signaling)Wnt pathway gene expression signatures (e.g., AXIN2, c-MYC)

Beyond the preview

Go deeper on Wnt-3a protein (Wnt3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wnt-3a protein (Wnt3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call